SCHEMBL22650497

SCHEMBL22650497

CC(C)(C)OC(=O)N1CCN(c2ccc(Nc3nccc(-c4cc(F)c5c(c4)C(C)(C)CO5)n3)nc2)C(=O)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DYRK2 Q92630 6/20 0.47
CDK6 Q00534 12/20 0.40
CCND3 P30281 5/20 0.40
CDK4 P11802 11/20 0.39
CSF1R P07333 2/20 0.39
PIK3CD O00329 1/20 0.39
CCNA2 P20248 3/20 0.37
CDK2 P24941 2/20 0.37
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37
CCNA1 P78396 1/20 0.37
ALK Q9UM73 1/20 0.37
CDK1 P06493 2/20 0.37
CCNB1 P14635 1/20 0.36
CCND1 P24385 1/20 0.36
CDK7 P50613 1/20 0.36
CCNH P51946 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29462408 1.00 DYRK2 (0.47) DYRK2CDK6CCND3CDK4CSF1R
SCHEMBL22650492 0.81 CDK6 (0.58) CDK6CCND3CDK4CSF1RPIK3CD
SCHEMBL22650772 0.81 CDK6 (0.46) CDK6CCND3CDK4CSF1RPIK3CD
SCHEMBL22650773 0.80 CDK4 (0.45) CDK6CCND3CDK4CSF1RCCNA2
SCHEMBL22650509 0.79 CDK6 (0.48) CDK6CCND3CDK4CSF1RPIK3CD
SCHEMBL21245536 0.77 CDK4 (0.69) CDK6CDK4CSF1RPIK3CDCCNA2
SCHEMBL22650507 0.75 CDK6 (0.45) CDK6CCND3CDK4CSF1RCCNA2
SCHEMBL22650784 0.74 DYRK2 (0.42) DYRK2CDK6CCND3CDK4CCNA2
SCHEMBL31589820 0.74 DYRK2 (0.42) DYRK2CDK6CCND3CDK4CCNA2
SCHEMBL29491176 0.74 DYRK2 (0.42) DYRK2CDK6CCND3CDK4CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114364675-A CDK inhibitors 上海齐鲁锐格医药研发有限公司 2022-04-15 CN disclosed
WO-2020224568-A1 CDK INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2020-11-12 WO disclosed